Price (delayed)
$3.37
Market cap
$252.08M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.26
Enterprise value
-$1.08M
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides
There are no recent dividends present for OSUR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.